# Novanta Inc: overview

NOVT · Nasdaq · CIK 1076930 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/novt.md) · [Financials](/companies/novt/financials.md) · [Filings](/companies/novt/filings.md) · [Insiders](/companies/novt/insiders.md)

Latest reported revenue: [$265.8m](/filings/0001193125-26-335404.md) for Q2 FY2026, three months to 2026-07-03, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-335404).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [244](/filings/0001193125-25-262774.md) | [238 d](/filings/0001193125-26-064230.md) | [233](/filings/0001193125-26-217064.md) | [241](/filings/0001193125-26-335404.md) | [248](/filings/0001193125-25-262774.md) | [258 d](/filings/0001193125-26-064230.md) | [258](/filings/0001193125-26-217064.md) | [266](/filings/0001193125-26-335404.md) |
| Gross margin | % | [44.7%](/filings/0001193125-25-262774.md) | [45.5% d](/filings/0001193125-26-064230.md) | [44.7%](/filings/0001193125-26-217064.md) | [44.3%](/filings/0001193125-26-335404.md) | [44.8%](/filings/0001193125-25-262774.md) | [43.8% d](/filings/0001193125-26-064230.md) | [44.1%](/filings/0001193125-26-217064.md) | [45.5%](/filings/0001193125-26-335404.md) |
| Operating margin | % | [13.3%](/filings/0001193125-25-262774.md) | [11.2% d](/filings/0001193125-26-064230.md) | [13.9%](/filings/0001193125-26-217064.md) | [6.2%](/filings/0001193125-26-335404.md) | [8.8%](/filings/0001193125-25-262774.md) | [9.6% d](/filings/0001193125-26-064230.md) | [10.7%](/filings/0001193125-26-217064.md) | [6.8%](/filings/0001193125-26-335404.md) |
| Net margin | % | [7.9%](/filings/0001193125-25-262774.md) | [6.9% d](/filings/0001193125-26-064230.md) | [9.1%](/filings/0001193125-26-217064.md) | [1.9%](/filings/0001193125-26-335404.md) | [4.3%](/filings/0001193125-25-262774.md) | [6.8% d](/filings/0001193125-26-064230.md) | [8.2%](/filings/0001193125-26-217064.md) | [4.7%](/filings/0001193125-26-335404.md) |
| Diluted EPS | $ per share | [0.53](/filings/0001193125-25-262774.md) | not reported | [0.59](/filings/0001193125-26-217064.md) | [0.12](/filings/0001193125-26-335404.md) | [0.30](/filings/0001193125-25-262774.md) | not reported | [0.51](/filings/0001193125-26-217064.md) | [0.30](/filings/0001193125-26-335404.md) |
| Free cash flow | $m | [19.5 d](/filings/0001193125-25-262774.md) | [59.3 d](/filings/0001193125-26-064230.md) | [27.4](/filings/0001193125-26-217064.md) | [11.7 d](/filings/0001193125-26-335404.md) | [4.2 d](/filings/0001193125-25-262774.md) | [5.1 d](/filings/0001193125-26-064230.md) | [47.5](/filings/0001193125-26-217064.md) | [57.5 d](/filings/0001193125-26-335404.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [707](/filings/0000950170-24-021689.md) | [861](/filings/0000950170-25-026131.md) | [882](/filings/0001193125-26-064230.md) | [949](/filings/0001193125-26-064230.md) | [981](/filings/0001193125-26-064230.md) |
| Gross margin | % | [42.5%](/filings/0000950170-24-021689.md) | [44.0%](/filings/0000950170-25-026131.md) | [45.4%](/filings/0001193125-26-064230.md) | [44.4%](/filings/0001193125-26-064230.md) | [44.4%](/filings/0001193125-26-064230.md) |
| Operating margin | % | [9.1%](/filings/0000950170-24-021689.md) | [12.0%](/filings/0000950170-25-026131.md) | [12.5%](/filings/0001193125-26-064230.md) | [11.6%](/filings/0001193125-26-064230.md) | [9.6%](/filings/0001193125-26-064230.md) |
| Net margin | % | [7.1%](/filings/0000950170-24-021689.md) | [8.6%](/filings/0000950170-25-026131.md) | [8.3%](/filings/0001193125-26-064230.md) | [6.8%](/filings/0001193125-26-064230.md) | [5.5%](/filings/0001193125-26-064230.md) |
| Diluted EPS | $ per share | [1.41](/filings/0000950170-24-021689.md) | [2.06](/filings/0000950170-25-026131.md) | [2.02](/filings/0001193125-26-064230.md) | [1.77](/filings/0001193125-26-064230.md) | [1.47](/filings/0001193125-26-064230.md) |
| Free cash flow | $m | [74.6](/filings/0000950170-24-021689.md) | [71.1](/filings/0000950170-25-026131.md) | [100](/filings/0001193125-26-064230.md) | [141](/filings/0001193125-26-064230.md) | [48.4](/filings/0001193125-26-064230.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/novt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $778.4m | 4,798,035 |  | Added +143,140 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $388.7m | 2,395,681 |  | Reduced −81,200 |
| [Daiwa Securities Group Inc.](/funds/1481045.md) | 2026-06-30 | $347.5m | 2,142,000 | Put | New +2,142,000 |
| [Allspring Global Investments Holdings, LLC](/funds/1890906.md) | 2026-06-30 | $297.5m | 1,817,594 |  | Added +40,900 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $260.7m | 1,606,928 |  | Reduced −6,287 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $233.0m | 1,436,785 |  | Added +97,621 |
| [Conestoga Capital Advisors, LLC](/funds/1163744.md) | 2026-06-30 | $197.6m | 1,217,963 |  | Reduced −231,852 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $160.3m | 987,728 |  | Added +50,754 |
| [CONGRESS ASSET MANAGEMENT CO](/funds/897378.md) | 2026-06-30 | $158.0m | 973,767 |  | Added +64,057 |
| [BAMCO INC /NY/](/funds/1017918.md) | 2026-06-30 | $138.0m | 850,494 |  | Reduced −64,589 |

## Recent filings

[All 1,138 filings](/companies/novt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 20:30 ET | [8-K/A](/filings/0001193125-26-412444.md) | 9.01 Financial statements and exhibits | 0001193125-26-412444 |
| 2026-08-05 | 21:00 ET | [10-Q](/filings/0001193125-26-335404.md) | Quarterly report, period 2026-07-03 | 0001193125-26-335404 |
| 2026-08-05 | 20:50 ET | [8-K](/filings/0001193125-26-335356.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335356 |
| 2026-07-27 | 12:15 ET | [8-K](/filings/0001193125-26-316947.md) | 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-316947 |
| 2026-06-09 | 21:00 ET | [8-K](/filings/0001193125-26-263979.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-263979 |
| 2026-06-09 | 10:02 ET | [8-K](/filings/0001193125-26-262867.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-262867 |
| 2026-05-29 | 20:45 ET | [8-K](/filings/0001193125-26-248524.md) | 5.07 Shareholder vote results | 0001193125-26-248524 |
| 2026-05-15 | 20:45 ET | [8-K](/filings/0001193125-26-227053.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-227053 |
| 2026-05-11 | 21:00 ET | [10-Q](/filings/0001193125-26-217064.md) | Quarterly report, period 2026-04-03 | 0001193125-26-217064 |
| 2026-05-11 | 20:45 ET | [8-K](/filings/0001193125-26-216984.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216984 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-064230.md), filed Feb 23, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1076930
- Tickers: NOVT, NOVTU
- Exchange: Nasdaq
- SIC code: 3690 Miscellaneous Electrical Machinery, Equipment & Supplies
- State of incorporation: A3
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.